Open access journal of the Ferrata-Storti Foundation, a non-profit organization
Letters to the Editor

Blinatumomab is associated with better post-transplant outcome than chemotherapy in children with high-risk first-relapse B-cell acute lymphoblastic leukemia irrespective of the conditioning regimen

St. Anna Children’s Hospital, St. Anna Children’s Cancer Research Institute, University Vienna, Vienna
Amgen Italia, Milan
MBBM Foundation, University of Milano-Bicocca, Monza
Amgen (Europe) GmbH, Rotkreuz
Charité Universitaetsmedizin CVK Berlin, Berlin
Medizinische Hochschule Hannover, Hannover
Amgen Inc., Thousand Oaks, CA
Amgen Research (Munich) GmbH, Munich
IRCCS Ospedale Pediatrico Bambino Gesù and Catholic University of the Sacred Heart, Rome
Haematologica Early view Sep 5, 2024 https://doi.org/10.3324/haematol.2024.285837

Abstract

Not available.

Figures & Tables

Article Information

Early view : Letters to the Editor
 
DOI
https://doi.org/10.3324/haematol.2024.285837
 
Published
2024-09-05
Published By
Ferrata Storti Foundation, Pavia, Italy
Print ISSN
0390-6078
Online ISSN
1592-8721
 
Copyright & Usage
Copyright (c) 2024 Ferrata Storti Foundation
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Article Usage

Online Views
297
PDF Downloads
156

Statistics from Altmetric.com

No Data
Navigate
For Authors
For Reviewers
For Advertisers
Education
Privacy
More
Copyright © 2024 by the Ferrata Storti Foundation | Web design ￫ | Development ￫
ISSN 0390-6078 print | ISSN 1592-8721 online